GlaxoSmithKline Aktie

17,12EUR
-0,06EUR
-0,35%
25.10.2021
14,25GBP
+0,04GBP
+0,31%
25.10.2021

WKN: 940561 / ISIN: GB0009252882

  Kaufen  
Verkaufen
oder
Werbung

GlaxoSmithKline Aktien News

25.10.21
The Zacks Analyst Blog Highlights: Tesla, Johnson & Johnson, PayPal, Verizon, Square and GlaxoSmithKline (Zacks)
17.10.21
Can Pfizer and GlaxoSmithKline Beat Johnson & Johnson's RSV Vaccine? (MotleyFool)
13.10.21
Is GlaxoSmithKline (GSK) Stock Undervalued Right Now? (Zacks)
12.10.21
GlaxoSmithKline activist calls for chair to quit (Financial Times)
12.10.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
11.10.21
Here's Why 2022 Could Be a Huge Year for GlaxoSmithKline (MotleyFool)
22.09.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
20.09.21
GlaxoSmithKline PLC : Director Declaration (Investegate)
02.09.21
GlaxoSmithKline (GSK) Outpaces Stock Market Gains: What You Should Know (Zacks)
31.08.21
GlaxoSmithKline PLC : SK bio & GSK start Ph3 Covid-19 vaccine trial (Investegate)
25.08.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
13.08.21
GlaxoSmithKline PLC : Director/PDMR Shareholding - amendment (Investegate)
11.08.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
29.07.21
GlaxoSmithKline plc (GSK) Q2 2021 Earnings Call Transcript (MotleyFool)
28.07.21
GlaxoSmithKline PLC : 2nd Quarter Results (Investegate)
23.07.21
GlaxoSmithKline PLC : Board Committee Changes (Investegate)
22.07.21
GlaxoSmithKline PLC : CEO Designate of new Consumer Healthcare company (Investegate)
16.07.21
GlaxoSmithKline PLC : GSK announces daprodustat phase 3 headline results (Investegate)
16.07.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
15.07.21
GlaxoSmithKline To Spin-Off Consumer Healthcare Business By Mid-2022 (Forbes)
09.07.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
02.07.21
Is a Bigger Shake-Up at GlaxoSmithKline on the Way? (MotleyFool)
02.07.21
: GlaxoSmithKline defends itself against activist Elliott, recognizing need for ‘improved and sustained value’ (MarketWatch)
24.06.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
23.06.21
London Markets: London stocks climb, driven by GlaxoSmithKline and resource names (MarketWatch)
23.06.21
The Zacks Analyst Blog Highlights: Exxon Mobil, Texas Instruments, GlaxoSmithKline, Norfolk Southern and Corning (Zacks)
23.06.21
GlaxoSmithKline PLC : GSK to deliver step-change in growth & performance (Investegate)
22.06.21
Top Stock Reports for Exxon Mobil, Texas Instruments & GlaxoSmithKline (Zacks)
22.06.21
GlaxoSmithKline PLC : ViiV/Halozyme sign exclusive licensing agreement (Investegate)
14.06.21
GlaxoSmithKline PLC : GSK and iTeos announce collaboration for EOS-448 (Investegate)
09.06.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
04.06.21
GlaxoSmithKline PLC : GSK recommend ADR holders reject mini-tender offer (Investegate)
27.05.21
GlaxoSmithKline and Vir win FDA emergency authorization for COVID antibody treatment in adults and children (Market Watch)
27.05.21
Sanofi and GlaxoSmithKline begin Phase 3 study of COVID-19 vaccine candidate (Market Watch)
27.05.21
GlaxoSmithKline PLC : Sanofi and GSK initiate new Phase 3 clinical study (Investegate)
27.05.21
GlaxoSmithKline PLC : GSK/Vir Sotrovimab FDA Emergency Use Authorization (Investegate)
24.05.21
The Zacks Analyst Blog Highlights: Sanofi, GlaxoSmithKline, Pfizer, Eli Lilly and Merck (Zacks)
24.05.21
GlaxoSmithKline PLC : Director/PDMR Shareholding (Investegate)
21.05.21
GlaxoSmithKline PLC : GSK/VIR sotrovimab receives positive EMA opinion (Investegate)
20.05.21
Better Buy for 2021: GlaxoSmithKline or Sanofi? (MotleyFool)
Seite: 1234

GlaxoSmithKline News

GlaxoSmithKline News: auf dieser Seite finden Sie alle GlaxoSmithKline News und Nachrichten zur GlaxoSmithKline Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch GlaxoSmithKline News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um GlaxoSmithKline News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.
Werbung
finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln